The University Hospitals Coventry and Warwickshire have announced the establishment of the West Midlands Alpha-1 Antitrypsin Deficiency Service.
The University Hospital Coventry already provides a multi-disciplinary service for patients with alpha-1 antitrypsin deficiency. Patients have access to a team of specialists that include consultants from the lung, liver and skin departments, with support from specialist nurses, physiotherapists, dieticians, psychologists, pharmacists and physiologists. The team is led by Consultant Respiratory Physician, Dr David Parr, who has worked extensively within the field and is recognised for his research on the use of CT scanning to measure lung disease in AATD.
The Coventry service is closely allied with the AATD service at University Hospital in Birmingham. This has the same multi-disciplinary approach and also provides services for genetic counselling and transplantation. The clinic at University Hospital Birmingham will be run by Dr David Parr and Dr Alice Turner.
Patients attending the West Midlands AATD service will have access to the same clinical approach, irrespective of whether they choose to attend the centre in Coventry or the centre in Birmingham. The close working relationship between the two teams will provide enhanced expertise to manage the complex clinical problems that may arise in AATD.
Patients will have the opportunity to participate in AATD research which is coordinated by the ADAPT programme in Birmingham. To obtain further information on research contact Dr Anita Pye at the ADAPT programme on 0121 371 3886.
Further information can be obtained by contacting Wendi Wallace in Coventry (02476 967697) or Rebecca Bray in Birmingham (0121 3713885).
The following links can be used to access information about the two hospitals;
Coventry – www.uhcw.nhs.uk/alpha
Birmingham – www.uhb.nhs.uk